Possible Side Effects While most users tolerate AOD9604 well, mild side effects can occur: Injection site reactions Redness, itching, or mild swelling may appear, especially if rotation of injection sites is inconsistent
Studies of dual GIP/GLP-1 agonists reported TBW (40.0%) and weight loss proportions (40.0%)
Testing may include SAM, SAH, the SAM-to-SAH ratio, methionine, homocysteine, copper, ceruloplasmin, zinc, CBC, comprehensive metabolic panel, kidney function, liver markers and exposure-specific testing when appropriate
The trial enrolled 329 Chinese adult patients with diabesity who exhibited representative real-world metabolic characteristics: Mean age: approximately 42 years Mean HbA1c: 8.02% Mean BMI: 33.0 kg/m Mean body weight: 90.5 kg Mean disease duration: 1.8 years Participants were randomized 1:1 to receive: Mazdutide (69 mg dose escalation) Semaglutide (1 mg standard treatment regimen) The treatment duration was 32 weeks, with evaluation of both glycemic and weight-related metabolic endpoints
doi: 10.1037/0022-006X.65.1.79
Online Weight Loss Programs WITH Membership - Prescription only $75/month Month-to-Month plan is $75/Month Membership Transform your weight loss journey with our affordable online program